NCT06924034

Brief Summary

This study aimed to investigate the effects of early-phase exercise-based supervised cardiac rehabilitation on functional exercise capacity, grip strength, fatigue, sleep quality, and health-related quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

March 30, 2025

Last Update Submit

April 5, 2025

Conditions

Keywords

Myocardial InfractionMIearly phasecardiac rehabilitation

Outcome Measures

Primary Outcomes (2)

  • Functional exercise capacity

    Functional exercise capacity assessment with 6-minute walk test distance as meters

    8 weeks

  • Functional exercise capacity

    Functional exercise capacity assessment with 30 s sit-stand test repetitions

    8 weeks

Secondary Outcomes (5)

  • SF-12 Health releated Quality of Life questionnaire

    8 weeks

  • MacNew Heart Disease Health releated Quality of Life questionnaire

    8 weeks

  • Fatigue

    8 weeks

  • sleep quality

    8 weeks

  • Grip strength

    8 weeks

Study Arms (2)

Cardiac Rehabilitation Program

EXPERIMENTAL

Patients who perform Phase I and Phase II Cardiac Rehabilitation Program

Other: Phase I and Phase II Cardiac Rehabilitation Program

Standard of care

NO INTERVENTION

The patients who received a usual care program

Interventions

The program consisted of two stages: an inpatient phase lasting until discharge, followed by an outpatient-supervised Phase II lasting eight weeks. In the intervention group, the participants in the inpatient phase received active-participatory lower extremity movements and progressive walking training (i.e., progressive walking in the room-corridor-hospital) to prepare them for discharge. The inpatient phase I was conducted with supervision following the American Heart Association recommendations. Participants in the intervention group were then administered phase II of the supervised CR program. Phase II CR was performed 3 non-consecutive days a week for 8 weeks as an aerobic exercise program.

Cardiac Rehabilitation Program

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically and medically stable patients with first MI
  • Prescribed cardiac rehabilitation by a cardiologist
  • Being between 30-65 years old
  • having ejection fraction (EF) of more than 20% (i.e. EF≥ 20%)
  • being volunteer to participate

You may not qualify if:

  • having coronary artery bypass graft surgery
  • Being diagnosed with chronic renal failure
  • Presence of unstable angina
  • Atrial fibrillation
  • Severe and symptomatic aortic stenosis
  • Presence of decompensated heart failure
  • Exercise-induced myocardial ischemia,
  • Pericardial disease,
  • Moderate-to-severe valve disease
  • COPD or asthma
  • BMI \> 40 kg/m2
  • Orthopedic and neurological problems that prevent exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylul University

Izmir, Balçova, 35330, Turkey (Türkiye)

Location

Related Publications (7)

  • Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS; American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); American association of Cardiovascular and Pulmonary Rehabilitation. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005 Jan 25;111(3):369-76. doi: 10.1161/01.CIR.0000151788.08740.5C.

    PMID: 15668354BACKGROUND
  • Sjolin I, Back M, Nilsson L, Schiopu A, Leosdottir M. Association between attending exercise-based cardiac rehabilitation and cardiovascular risk factors at one-year post myocardial infarction. PLoS One. 2020 May 11;15(5):e0232772. doi: 10.1371/journal.pone.0232772. eCollection 2020.

    PMID: 32392231BACKGROUND
  • Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2022 Mar;19(3):180-194. doi: 10.1038/s41569-021-00611-7. Epub 2021 Sep 16.

    PMID: 34531576BACKGROUND
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5. No abstract available.

    PMID: 23747642BACKGROUND
  • Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007 Oct 9;116(15):1653-62. doi: 10.1161/CIRCULATIONAHA.107.701466. Epub 2007 Sep 24.

    PMID: 17893274BACKGROUND
  • Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ. 2010 Jan 19;340:b5631. doi: 10.1136/bmj.b5631.

    PMID: 20085991BACKGROUND
  • Peixoto TC, Begot I, Bolzan DW, Machado L, Reis MS, Papa V, Carvalho AC, Arena R, Gomes WJ, Guizilini S. Early exercise-based rehabilitation improves health-related quality of life and functional capacity after acute myocardial infarction: a randomized controlled trial. Can J Cardiol. 2015 Mar;31(3):308-13. doi: 10.1016/j.cjca.2014.11.014. Epub 2014 Dec 11.

    PMID: 25633911BACKGROUND

MeSH Terms

Conditions

Myocardial Infarction

Interventions

Clinical Trials, Phase I as Topic

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Clinical Trials as TopicClinical Studies as TopicEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Sevgi Ozalevli, Prof.

    Dokuz Eylul University

    STUDY DIRECTOR
  • Özge Ocaker Aktan, PhD (c)

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study was designed as a prospective and Randomized Controlled experimental study. Participants were randomly divided into two groups in a 1:1 ratio; the study group and the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 30, 2025

First Posted

April 11, 2025

Study Start

July 3, 2023

Primary Completion

May 31, 2024

Study Completion

June 25, 2024

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations